Epigenetics and autosomal dominant polycystic kidney disease.
about
Experimental therapies and ongoing clinical trials to slow down progression of ADPKDPolycystic kidney disease - where gene dosage countsEpigenetics of Renal Development and DiseaseSirtuin 1 inhibition delays cyst formation in autosomal-dominant polycystic kidney diseaseHDAC6 regulates epidermal growth factor receptor (EGFR) endocytic trafficking and degradation in renal epithelial cells.Therapeutic targeting of BET bromodomain protein, Brd4, delays cyst growth in ADPKD.Epigenetic silencing of the MUPCDH gene as a possible prognostic biomarker for cyst growth in ADPKD.HDAC inhibitors in kidney development and disease.New treatments for autosomal dominant polycystic kidney diseaseHistone deacetylation meets miRNA: epigenetics and post-transcriptional regulation in cancer and chronic diseases.Therapeutic targets for polycystic kidney disease.Recent Trends in ADPKD Research.Epigenetic Regulation in Cystogenesis.Validation of Effective Therapeutic Targets for ADPKD Using Animal Models.Diagnostic Evaluation as a Biomarker in Patients with ADPKD.Genome-wide methylation profiling of ADPKD identified epigenetically regulated genes associated with renal cyst development.Lysine methyltransferase SMYD2 promotes cyst growth in autosomal dominant polycystic kidney disease.Targeting new cellular disease pathways in autosomal dominant polycystic kidney disease.Severe Polycystic Liver Disease Is Not Caused by Large Deletions of the PRKCSH Gene.Inhibition of HDAC6 activity in kidney diseases: a new perspective.
P2860
Q27001230-30031822-00DE-4E4C-8027-9B4967B8F3F3Q27012746-B83C92CB-A4B4-45AB-838C-11AA6CA647B6Q28079434-2A095A8D-B9B4-49BC-A6F7-675E8C455045Q33914623-031F8C7E-1195-4083-A054-F3BC7A85828CQ34477986-BB9029EF-39F7-4EE5-9167-9820DFE60CFAQ35766387-5F38E20C-7AB2-4D15-BB83-8685D5806EBAQ36158683-F2F23C01-1E0E-460D-8E04-34F155EB0347Q37115414-3B2FC55E-F217-4D72-AC91-A1D0BD91C4ACQ38099698-64E819EA-4BF2-4E4D-8F65-A9D8F7F12F05Q38376048-CE6B9F77-7E8F-4FEC-9F95-C36CEC376B2FQ38578289-17D73F9A-9E7E-469B-B138-539754B987BCQ38978449-7E894825-406B-401D-AB1D-0DA8A6151558Q38978465-B91CDB1E-5F4E-4BF3-AA74-86CD2C8D2515Q38978468-9B1C3CC7-6D44-4C0B-A90B-B790A64AE0BFQ38978474-20A8BECA-CCB4-457E-ADE2-0A6DAFD71B0EQ39078035-7096B18A-FE32-431C-8EE4-712AB5FA826DQ41661686-224A50EA-FC0D-4973-912B-B84F6CF15913Q53035502-7F071E81-3570-46AA-AD51-460E5D495A81Q55043077-42268C64-6A69-4101-877C-50785BEE5B87Q55442467-1DFA1E01-D34F-4A59-83E6-9E4B23739063
P2860
Epigenetics and autosomal dominant polycystic kidney disease.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Epigenetics and autosomal dominant polycystic kidney disease.
@ast
Epigenetics and autosomal dominant polycystic kidney disease.
@en
type
label
Epigenetics and autosomal dominant polycystic kidney disease.
@ast
Epigenetics and autosomal dominant polycystic kidney disease.
@en
prefLabel
Epigenetics and autosomal dominant polycystic kidney disease.
@ast
Epigenetics and autosomal dominant polycystic kidney disease.
@en
P2860
P1476
Epigenetics and autosomal dominant polycystic kidney disease.
@en
P2093
Xiaogang Li
P2860
P304
P356
10.1016/J.BBADIS.2010.10.008
P407
P577
2010-10-20T00:00:00Z